Post-approval commitment for HSA-2023-0012. Category: Post-Approval Study. Priority: low.

Commitment ID
COM-012
Application
Authority
Health Sciences Authority
Category
Post-Approval Study
Priority
low
Status
Blocked
Due Date
2025-02-17
Completed At
—
Owner
Lieselotte van der Berg
Created
2023-03-28
Description

Provide confirmatory bioequivalence study for 200 mg strength

Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.